Dystrophin-Glycoprotein Complex (DGC; Sarcospan) Inhibitors

The Dystrophin-Glycoprotein Complex (DGC) is a critical assembly of proteins that connects the cytoskeleton of a muscle cell to the extracellular matrix, providing structural stability and protection against muscle fiber damage during contraction and relaxation. Dystrophin, the key component of this complex, anchors to actin in the cytoskeleton internally and to β-dystroglycan, which in turn binds to α-dystroglycan, forming a link to laminin in the extracellular matrix. The DGC is crucial for maintaining the integrity of muscle fibers; mutations in the dystrophin gene disrupt this complex, leading to muscular dystrophies, such as Duchenne Muscular Dystrophy (DMD).

Functionally, the DGC plays a vital role in transmitting mechanical forces across the muscle cell membrane (sarcolemma), thereby protecting muscle fibers from injury. It also participates in cell signaling pathways: the complex is involved in modulating intracellular calcium levels and in regulating nitric oxide synthesis, which are essential for muscle function and adaptation. Targeting the Dystrophin-Glycoprotein Complex (DGC) using small molecules allows for a deeper understanding of its mechanistic role in muscle cell function and pathology. By disrupting or inhibiting the DGC, researchers can observe the consequences on muscle cell integrity, signaling, and mechanical stability, thus elucidating the essential functions of the complex. Such studies can reveal how the DGC contributes to the maintenance of muscle cell structure and the transmission of mechanical force from the intracellular cytoskeleton to the extracellular matrix.